Journalartikel
Autorenliste: Denomme, Gregory A.; Anani, Waseem Q.; Avent, Neil D.; Bein, Gregor; Briggs, Lynne B.; Lapadat, Razvan C.; Montemayor, Celina; Rios, Maria; St-Louis, Maryse; Uhl, Lynne; Wendel, Silvano; Flegel, Willy A.
Jahr der Veröffentlichung: 2017
Seiten: 277-291
Zeitschrift: Therapeutic Advances in Hematology
Bandnummer: 8
Heftnummer: 10
ISSN: 2040-6207
eISSN: 2040-6215
Open Access Status: Green
DOI Link: https://doi.org/10.1177/2040620717729128
Verlag: SAGE Publications
Abstract:
This review summarizes the salient points of the symposium Red Cell Genotyping 2015: Precision Medicine' held on 10 September 2015 in the Masur Auditorium of the National Institutes of Health. The specific aims of this 6th annual symposium were to: (1) discuss how advances in molecular immunohematology are changing patient care; (2) exemplify patient care strategies by case reports (clinical vignettes); (3) review the basic molecular studies and their current implications in clinical practice; (4) identify red cell genotyping strategies to prevent alloimmunization; and (5) compare and contrast future options of red cell genotyping in precision transfusion medicine. This symposium summary captured the state of the art of red cell genotyping and its contribution to the practice of precision medicine.
Zitierstile
Harvard-Zitierstil: Denomme, G., Anani, W., Avent, N., Bein, G., Briggs, L., Lapadat, R., et al. (2017) Red cell genotyping precision medicine: a conference summary, Therapeutic Advances in Hematology, 8(10), pp. 277-291. https://doi.org/10.1177/2040620717729128
APA-Zitierstil: Denomme, G., Anani, W., Avent, N., Bein, G., Briggs, L., Lapadat, R., Montemayor, C., Rios, M., St-Louis, M., Uhl, L., Wendel, S., & Flegel, W. (2017). Red cell genotyping precision medicine: a conference summary. Therapeutic Advances in Hematology. 8(10), 277-291. https://doi.org/10.1177/2040620717729128
Schlagwörter
APPLYING MOLECULAR IMMUNOHEMATOLOGY; CHAIN-REACTION ANALYSIS; D D-U; molecular immunohematology; PARTIAL-D PHENOTYPES; red cell genotyping; RHCE ALLELE; RHD GENE; TRANSFUSED THALASSEMIC PATIENTS; transfusion precision medicine; WEAK D PHENOTYPES